Global COVID-19 Antibody Detection Kits

The COVID-19 Antibody Detection Kits are specially designed for the detection & diagnosis of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgM/IgG antibodies in human serum, plasma, or blood. The worldwide spread of COVID-19 adversely affected the global economies and hampered the growth of numerous industries. Therefore, the demand for COVID-19 antibody detection kits is leveraged by the government authorities to detect the virus at an early stage and limit the spread of the virus. Thus, the rising case of coronavirus across the globe is stimulating the demand for COVID-19 antibody detection kits over the forecast years. For instance: as per Statista, the total number of coronavirus cases in the U.S. was 20 on 19th March 2020 and has tremendously risen by 1,658,896 confirmed cases of COVID-19 with 98,119 deaths in the U.S. on 28th May 2020. Also, on 31st January 2020, the first 2 cases of coronavirus were confirmed in the United Kingdom and have significantly reached 267,240 confirmed cases of coronavirus in the United Kingdom on 27th May 2020. Also, as per World Health Organization, on March 12th, 2020, over 6,941 new cases of coronavirus were detected across the globe which increased to over 1,22,918 till June 1st, 2020, leads to the total cases of 60,57,853 of COVID-19 worldwide. Moreover, rapid advancements in healthcare facilities & ongoing government approvals for Covid-19 test kits to efficiently detect and cope up with the spread of the virus is the factor driving the growth of the market over the forecast years. However, the Limited availability of kits and a dearth of skilled professionals is hampering the market growth.

Global COVID-19 Antibody Detection Kit Market is valued at approximately USD 5002.2 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 10.40% over the forecast period 2020-2027.  The regional analysis of the global COVID-19 Antibody Detection Kit market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising cases of COVID-19 in the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising cases of a novel coronavirus in the Asian countries, along with increasing government funding to tackle the COVID-19 situation would create lucrative growth prospects for the COVID-19 Antibody Detection Kit market across the Asia-Pacific region.

Major market players included in this report are Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Biotech, Mayo Clinic Laboratories, Chembio Diagnostics, Innovita Biological Technology

The detailed segments and sub-segment of the market are explained below:

By Product Type: Immunoglobulin M (IgM), Immunoglobulin G (IgG)

By End-user: Hospital, Scientific Research, Diagnostic Centre

Review our report at

To review more reports on Upcoming topics, visit us at

Data drives better decisions
Bizwit Research & Consulting LLP